Business
Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029
Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2026.
About this update from Azenta, Inc.
[{"type":"list","items":[{"val":[{"type":"text","content":"FY'26 total reported revenue from continuing operations to range between approximately $603 to $621 million","length":111,"tagName":"p"}]},{"val":[{"type":"text","content":"FY'26 organic revenue is now expected to range from down approximately 2% to up 1%, compared to prior guidance of 3% to 5% growth","length":133,"tagName":"p"}]},{"val":[{"type":"text","content":"FY'26 Adjusted EBITDA margin is now expected to range from down approximately 125 basis points to flat, compared to prior expectations of approximately 300 basis points of expansion","length":185,"tagName":"p"}]},{"val":[{"type":"text","content":"Long-range plan timing updated to 2029 versus 2028 before in connection with revised 2026 guidance. Market opportunities, strategic priorities, and value creation framework remain intact.","length":187,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":616,"olType":false},{"type":"text","content":"BURLINGTON, Mass., May 5, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2026.","length":152,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"11","rowspan":"1","style":"PADDING-RIGHT:0.83em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;TEXT-ALIGN:LEFT;","val":[{"type":"text","content":"","length":0,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"11","rowspan":"1","style":"PADDING-RIGHT:0.83em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;TEXT-ALIGN:LEFT;","val":[{"type":"text","content":"","length":0,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"11","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;TEXT-ALIGN:LEFT;","val":[{"type":"text","content":"The results of B Medical Systems are treated as discontinued operations and reflected in total diluted EPS, following the Company's announcement in the first fiscal quarter of 2025 of its intention to pursue a sale and the entry into a definitive agreement to sell the business.","length":284,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"11","rowspan":"1","style":"PADDING-RIGHT:0.83em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;","val":[{"type":"text","content":"","length":0,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.83em;PADDING-LEFT:0.17e...